25 LLC’s Idexx Laboratories IDXX Stock Holding History

25 LLC’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$533	–	253
2023 Q2	$533	Buy	+1	New	+$479	﹤0.01%	487

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

25 LLC's IDXX Position: Q3 2023 in Review

25 LLC sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 1 share — an estimated $533 sold.

25 LLC first reported a position in IDXX in Q2 2023 and held it in 1 quarter. The position peaked at $533 in Q2 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

25 LLC reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
25 LLC sold 1 Idexx Laboratories share in Q3 2023, an estimated $533.
25 LLC first reported a position in Idexx Laboratories in Q2 2023 and held it in 1 quarter.
25 LLC's Idexx Laboratories position peaked at $533 in Q2 2023.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.